China’s New Formulary In Consultation; Entries Estimated To Double
This article was originally published in PharmAsia News
China is seeking consultation on its new national Essential Drug List, with entries expected to double, including the addition of 400 Western medicines and 200 TCMs.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.